Congenital cataract is the most frequent inherited ocular disorder and the most leading cause of lifelong visual loss. The screening of pathogenic mutations can be very challenging in some cases, for congenital cataracts are clinically and genetically heterogeneous diseases. The aim of this study is to investigate the mutation spectrum and frequency of 54 cartaract-associated genes in 27 Chinese families with congenital cataracts. Variants in 54 cataract-associated genes were screened by targeted next-generation sequencing (NGS) and then validated by Sanger sequencing. We identified pathogenic variants in 62.96% (17/27) of families, and over 52.94% (9/17) of these variants were novel. Among them, three are splicing site mutations, four are nonsense mutations, seven are missense mutations, two are frame shift mutations and one is intronic mutation. This included identification of: complex ocular phenotypes due to two novel PAX6 mutations; progressive cortical cataract and lamellar cataract with lens subluxation due to two novel CRYGS mutations. Mutations were also found in rarely reported genes including CRYBA4, CRYBA2, BFSP1, VIM, HSF4, and EZR. Our study expands the mutation spectrum and frequency of genes responsible for congenital cataracts. Targeted next-generation sequencing in inherited congenital cataract patients provided significant diagnostic information.
In order to identify the genetic cause of our newly recruited 27 families with congenital cataracts, we applied targeted exome sequencing using SureSelect Target Enrichment Kit. 17 mutations were identified in the 27 families, and 13 mutations were considered to be novel. Mutations were identified in 12 genes and we found a high mutation detection rate of approximately 62.96% in these families.
Results
Next Generation Sequencing. The present study recruited 27 families with congenital cataract. Targeted exome sequencing results of the 27 probands detected 6,024 variants in the 54 known genes (Table S1 ). Bioinformatics analysis of these mutations revealed that 30 of them are potential pathogenic (Table S2) .
Validation by Sanger sequencing. All of 30 mutations are confirmed by Sanger sequencing in probands and available family members. Among them, seventeen mutations were confirmed to be cosegregated with congenital cataracts (Table 1) . SIFT predicts substitutions with scores less than 0.05 as deleterious, Polyphen-2 predicts substitutions with scores greater than 0.75 as "probably damaging". The pedigrees of seventeen families are presented in Fig. 1 .
Ten of seventeen mutations were identified in crystallin genes, while other seven mutations identified in six genes. Two mutations are in PAX6 (MIM: 607108); three mutations are in cytoskeletal protein (BFSP1 (MIM: 611391), VIM (MIM: 116300), and EZR); and one mutation each in MIP (MIM: 154050) and HSF4 (MIM: 602438). Among seventeen mutations, three are splicing site mutations, four are nonsense mutations, seven are missense mutations, two are frame shift mutations and one is intronic mutation. None of these seventeen mutations was detected in 100 controls. Nine mutations were considered as novel disease-causing mutations (DNA sequencing results provided in Fig. 2) ; while four have been previously linked to congenital cataracts [8] [9] [10] [11] ( Figure S1 ). However, four pathogenic mutations (in family 6, 10, 14 and 18) could not be strongly associated with congenital cataracts due to the limited DNA samples of the family members and bioinformation prediction results ( Figure S2 ).
Clinical findings.
All patients in this study had different types of congenital cataracts without other systemic diseases. Other ophthalmic findings of seventeen probands were listed in Table 2 . Two families (family 24 and 27) with PAX6 mutation showed aniridia. Twelve phenotypes of probands with congenital cataract were recorded (Fig. 3) , while other five probands underwent cataract surgery prior to this study. The phenotype of these families could only determinate by their medical record.
Discussion
More than 40 genes have been associated with congenital cataracts. Screening of these genes in groups of congenital cataract patients showed that the mutation frequencies have great differences [12] [13] [14] [15] . Sanger sequencing confirmed that seventeen mutations are disease-causing. Our study revealed that mutations in crystallin genes are still the leading causes of nonsyndromic congenital cataracts with a frequency of 37.03%.
Mutations in the Lens-Specific Crystallin Genes. Ten crystallins gene mutations were found in 27 families corresponding to 37.03% of the analyzed families, which is in the same magnitude as the percentage of crystallin mutations in Denmark group (36%) 14 . However, only 2 crystallin mutations (5%) were identified among 32 families with autosomal dominant congenital cataracts (ADCC) in southeastern Australia 16 . This difference of results may be influenced by different ethnic background and selection bias of family samples.
Three crystallins gene mutations have been associated with congenital cataracts. CRYGD p.P24T is a hotspot for mutation which has been reported for several times 10, [16] [17] [18] [19] . Previous studies have showed different phenotypes (e.g. coralliform, cerulean, lamellar) of CRYGD p.P24T. Our proband showed a coralliform cataract, which is one of the most common phenotype of this mutation [20] [21] [22] [23] . CRYBB2 p.Q155X is another hotspot for mutation in congenital cataracts 13, 24, 25 . Phenotypes of this mutation have been described as cerulean cataracts, which is also in correspondence with the proband of family16. CRYGD p.R15S has been reported once by Zhang and colleagues with a phenotype of coraliform cataracts 11 . The proband of family also present a coralliform cataract. Our results confirmed these recurrent mutations, and further expanded the mutation spectrum of congenital cataracts.
Two novel nonsense mutations CRYBB2 p.W151X and CRYBA1 p.Q203X may terminate the reading frame before the authentic stop codon. Nonsense-mediated decay (NMD) is the process by which mRNAs containing pre-mature termination codons (PTCs) are degraded before production of supposed truncated proteins 26, 27 . Two CRYGS mutations p.G18D and p.G75V has been detected in two families. The CRYGS p.G18V mutation has been associated with dominant progressive cortical cataract 28 , and reported to increase the gammaS-crystallin sensitivity to thermal and chemical stress 29 . Figure 1 . Pedigrees of the families with mutations. Squares indicate men and circles women; black and white symbols represent affected and unaffected individuals, respectively. The proband is marked with an arrow, and asterisks indicate those members enrolled in this study.
Kingsley et al. suggested that the potential mechanism for CRYGS p.G18V mutation to cause cataract formation is the depletion of the finite αB-crystallin population of the lens 30 . The results of their study indicated normal association and structural properties of the G18V mutant γS-crystallin under mild conditions, but increased sensitivity stress, which were thus consistent with the progressive nature of the cataracts in the family. The CRYGS p.G18D mutation, located in the same locus of p.G18V, may also alter the sensitivity to thermal and chemical stress, and deplete αB-crystallin of the lens as well. SWISS-MODEL revealed both p.G18V and p.G18D are significantly different from wild type (Fig. 4) . The phenotype of CRYGS p.G18D mutation is also progressive cortical and sutural cataract, and this is in accordance with the phenotype p.G18D caused. The novel deletion mutation (c.271_273delGAG) in exon 4 of CRYBA1 was identified in a family with autosomal dominant congenital cataracts. Several deletion mutations have been identified in CRYBA1 gene 31, 32 and CRYBA1c.272_274delGAG has been widely reported [33] [34] [35] [36] . Xu indicated that DeltaG91 mutation of CRYBA1altered protein-protein interaction between human lens betaA1-crystallins, and lead to protein insolubilization and contribute to cataracts 37 . In our study, a novel in-frame deletion of three bp was dcted in exon 4 of CRYBA1 (c.271_273delGAG). Though this is a novel mutation on DNA level, it also leads to a DeltaG91 deletion like c.272_274delGAG mutation dose. Thus, this mutation was predicted to cause the same protein insolubilization of betaA1-crystallins as c.271_273delGAG dose. The mutation found in CRYBA4 (c.26C > T, p.A9V) is the first cataract-associated CRYBA4 mutation with a dominant pattern. This mutation has been previously detected by Sun et al. 15 . They suggested that CRYBA4 p.A9V may be the pathogenic mutation of a Chinese family with congenital cataracts. But they cannot be sure due to bioinformation prediction results and limited family members. Our results confirmed that this mutation is cosegregated with congenital cataracts within the family, verified their hypothesis.
Mutations in the cytoskeletal protein.
The structural framework of lens cells is determined by the interaction of the cytoskeleton and the crystallins within the cytoplasm. Beaded filament is a type of intermediate filament which is unique to the lens fiber cells 6 . They are made up of BFSP1 (also called CP115 or filensin) and BFSP2 (also called CP49 or phakinin), highly divergent intermediate filament proteins that combine in the presence of crystallin to form the appropriate beaded structure 4 . Several different mutations of BFSP2 have been linked to ADCCs [38] [39] [40] , while BFSP1gene mutations have been linked to both autosomal dominant pattern (p.D348N) 41 and autosomal recessive pattern (p.T246del74fsX6) 42 . To date, only these two BFSP1 disease-causing mutations have been reported. Thus, BFSP1 c.625 + 3A > G mutation we detected was the first report of BFSP1 splicing site mutation.
We also detected two cytoskeletal protein mutations EZR c.1597-7insTAAT and VIM p.Q208R. Lin et al. has linked several EZR mutations to age-related cataracts 43 . The mutation of VIM (p.E151K) is associated with inherited congenital cataracts. The mutant formed an aberrant vimentin cytoskeleton and increased the proteasome activity in transfected cells 44 . Thus, further investigation of EZR c.1597-7insTAAT and VIM p.Q208R are needed to clarify the pathogenicity of these two mutations.
Mutations in PAX6 gene. Congenital aniridia with cataract is linked to a mutation of the PAX6 genes.
Human PAX6 is composed of two DNA-binding domains: the paired domain (PD) of 128 amino acids and the homeodomain (HD) of 61 amino acids separated by a linker region of 79 amino acids, and is followed by a proline, serine, threonine-rich (PST) domain of 79 amino acids which have transcriptional trans-activation function 45 . It is a highly conserved transcription factor which regulates the tissue-specific expression of various molecules, hormones, and structural proteins. It is required for the development of the nervous system, eyes, nose, pancreas, and pituitary gland [46] [47] [48] . As a crucial transcriptional factor, PAX6 mutations may affect a broad range of structures during development. Therefore, the phenotypes of different PAX6 mutations can be very diverse. PAX6 mutations is characterized by partial or complete absence of the iris accompanied with other ocular abnormalities such as cataract, glaucoma 49 , corneal degeneration 50 , microphthalmia 51 , foveal hypoplasia 52 , optic-nerve malformations 53 . Some individuals with PAX6 mutation developed other systemic diseases such hepatoblastoma, polydactylia 54 . PAX6 regulates numerous downstream genes, and its expression level is also regulated by several factors during eye development. Thus, the aniridia phenotype may vary even within the family, and the obvious genotype-phenotype correlation was very hard to identified 54 . However, Lin et al. reviewed the mutations archived in the PAX6 AllelicVariant Database, and found that over three-quarters of aniridia cases are caused by mutations that introduce a PTC into the open reading frame of PAX6 50 . It was widely belived that truncations of Pax6 can usually cause aniridia phenotype, due to haploinsufficiency 55 . Patients with PAX6 contiguous deletion, may have relatively severe phenotype, including bilateral complete absence of iris and foveal hypoplasia 49 . The two novel PAX6 mutations detected in our study were p.E265fs and p.W114X. Patient with p.E265fs mutation showed a partial absence of the iris, congenital coralliform cataracts and nystagmus (Fig. 3) . This frameshift mutation is very close to p. E265fs. All patients in family 27 with p.W114X mutation showed a complete absence of iris, congenital anterior and posterior polar cataracts, as well as nystagmus. PAX6 nonsense mutations been widely reported (p.Arg240X, p.W100X, p.R103X, etc.), and linked to aniridia with congenital cataract [56] [57] [58] . The phenotypes caused by two PAX6 mutations in this study were in accordance with these previous results. Liu et al. revealed the PAX6 mRNA level was about 50% lower in patients caused by p.A266fs mutation than in unaffected family members, indicating that this mutation caused nonsense-mediated mRNA decay (NMD) 59 . Since NMD is a common pathogenic mechanism of nonsense and frameshift mutations, we hypothesized that nonsense-mediated decay (NMD) may be the pathogenic mechanism of two PAX6 mutations we identified as well.
In conclusion, our results showed that mutations in the 54 known genes were responsible for about 62.96% of this set of Chinese families with congenital cataracts. And mutations in the crystallin gene were identified in 37.03% of the families. Therefore, we believed that targeted exome sequencing is an efficient method in disease-causing mutation identification.
Materials and Methods
Patient Recruitment. The research protocols of this study adhered to the guidelines of the Declaration of Helsinki and were approved by the Medical Ethics Committees of the Second Affiliated Hospital, College of Medicine, Zhejiang University (Hangzhou, China). Appropriate informed consent from each participant was obtained.
Among 27 families, 24 were diagnosed with congenital cataracts, while 3 were diagnosed with aniridia and congenital cataract. 25 families with family history showed autosomal dominant inheritance, and 2 were sporadic patients. Available individuals indicated in Fig. 1 were given complete physical, ophthalmic examinations. One hundred unrelated healthy subjects from the same ethnic background were recruited as controls. Peripheral blood was collected by venipuncture in EDTA-coated Vacutainer tubes (BD, New Jersey, USA) and stored at −20 °C.
Scientific RepoRts | 7: 1219 | DOI:10.1038/s41598-017-01182-9 DNA Extraction and Next Generation Sequencing. Genomic DNA of 27 probands was isolated from the 2 ml peripheral blood samples using QIAamp DNA Blood kits (Qiagen, Hilden, Germany). Then the purity and quantity of DNA samples were measured by the NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, Massachusetts). Genomic DNA was shearing by CovarisTM system. Then sample preparation by following the manufacturer's standard procedure using Truseq DNA Sample preparation Kit (Illumina, Inc, San Diego, CA).
The coding exons, flanking regions and promotor regions of 54 genes related to inherited cataracts were selected and captured using a SureSelect Target Enrichment Kit (Agilent technologies, Inc, USA). The kit included 5,721 probes and could enrich about 551 exons and cover about 94.7% targeted regions. The enrichment libraries were sequenced on Illumina HiSeq2000 Sequencer (Illumina, Inc, San Diego, CA); the average sequencing depth was 500-fold.
Bioinformatics Analysis. The low quality reads and adaptor sequences were filtered out with the FASTX program. Picard program was used to remove the PCR duplicates. After high-quality reads were retrieved, the clean data were aligned using BWA program according to human genome parameters (hg19). Subsequently, we determined SNPs using the SOAPsnp program, realigned the reads with BWA, and detected the deletions or insertion (InDels) with the GATK software. After SNPs are identified, we use ANNOVAR to do annotation and classification. Finally, all nonsynonymous variants were evaluated by three algorithms, SIFT (http://sift.jcvi.org/), PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), Mutation Tester (http://www.mutationtaster.org/).
Expanded Validation. DNA samples of probands were taken for further Sanger sequencing, to confirm the potential pathogenic variants detected by exome sequencing. Polymerase chain reaction (PCR) was performed in a 20 μl reaction system using the primer pairs previously published 60 or designed by Primer Premier 6.0 (Table S3) . PCR products were isolated using electrophoresis on 3% agarose gels and sequenced using the BigDye Terminator Cycle sequencing kit V 3.1 (ABI-Applied Biosystems; Sangon Co, China) on an ABI PRISM 3730 Sequence Analyzer (ABI). Sequencing results were analyzed using Chromas 2.3.0 and compared with sequences from NCBI human genome database. Confirmed variants were further sequenced in the all available family members and 100 control individuals.
